EQT AB (publ) (EQT)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 295.50 |
|---|---|
| 52-week range | 259.00 – 379.85 |
| Return, 1 month / 3 months | −1.5% / −5.0% |
| Return, 1 year / 3 years | −11.5% / +41.0% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 34.5% |
| Worst drawdown (1 year) | -29.5% |
| Average daily value traded | 480.88M SEK |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
EQT AB is a Swedish investment firm based in Stockholm that raises and manages private capital funds on behalf of institutional investors. It invests through private equity, infrastructure, real estate and venture capital strategies, taking stakes in unlisted companies and assets across Europe, North America and Asia. Its clients are mainly pension funds, insurance companies, endowments and other institutional limited partners, and it also offers some co-investment and advisory-related services.
EQT AB (publ) trades under the code EQT on the Stockholm Exchange in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
EQT AB (publ) (EQT) trades on the Stockholm Exchange in Sweden. It last closed at SEK 295.50 on 19 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 258 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.5% and over the last three months it fell 5.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -3.1% | ||
| From 52-week high | -20.5% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.0% | ||
| 6-month return | -7.4% | ||
| 12-month return, skipping the last month | -10.2% | ||
| Stability (higher is calmer) | 70 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.5% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 480.88M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +3.0% |
|---|---|
| 1 month | −1.5% |
| 3 months | −5.0% |
| 6 months | −7.4% |
| 1 year | −11.5% |
| 3 years | +41.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 310.08 / 305.04 |
|---|---|
| Golden / death cross (60 days) | Golden, 36 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.09 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 May 2026 | SEK 2.5000 |
| 28 Nov 2025 | SEK 2.1500 |
| 28 May 2025 | SEK 2.1500 |
| 29 Nov 2024 | SEK 1.8000 |
| 28 May 2024 | SEK 1.8000 |
| 29 Nov 2023 | SEK 1.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.